Affiliation:
1. University of Sao Paulo
2. A.C.Camargo Cancer Center
3. Valencian Institute of Oncology Foundation
4. Mexico Hospital
5. San Juan de Dios Hospital
Abstract
Abstract
Background
Ovarian clear cell carcinomas (OCCCs) are rare, aggressive and chemoresistant tumors. Geographical and ethnic differences in the incidence of OCCC have been reported with a higher incidence in Asiatic countries. There is a paucity of information regarding OCCC in Latin America (LA) and other countries.
Methods
Here, we characterized two cohorts of 33 patients with OCCC from LA (24 from Brazil and 9 from Costa Rica) and a cohort of 27 patients from Spain. Genomic analysis was performed for 26 OCCC using the OncoScan platform. Tumors were classified according to their genomic landscapes into the Simplex-like (Sxl), Firestorm-like (FSl) and Sawtooth-like (STl) subgroups.
Results
The median overall survival (OS) was not significantly different between the cohorts. Genomic landscapes were characterized by different homologous recombination deficiency (HRD) levels. OCCCs with MYC-amplified tumors bearing a concomitant loss of a region in chromosome 13q12-q13 that includes the BRCA2 gene (MB subgroup) had the longest OS. In contrast, non-MB patients carrying a high number (> 30) of total copy number (CN) aberrations presented the shortest OS (PS subgroup). Furthermore, amplification of the ASH1L gene was also associated with a shorter OS. No difference in the distribution of genomic landscapes or MB and PS profiles was detected between patients from the different cohorts. Initial-stage OCCCs with early progression were characterized by gains in the JNK1 and MKL1 genes.
Conclusions
Our results provide new data from understudied OCCC populations and reveal new potential markers and therapeutic targets for OCCCs.
Publisher
Research Square Platform LLC
Reference76 articles.
1. Anglesio MS, Carey MS, Köbel M, MacKay H, Huntsman DG. Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010. Gynecol Oncol. 2011;121:407–15.
2. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy;Sugiyama T;Cancer,2000
3. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers;Chan JK;Gynecol Oncol,2008
4. Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: A meta-analysis;Lee YY;Gynecol Oncol,2011
5. Association between endometriosis and risk of histological subtypes of ovarian cancer: A pooled analysis of case-control studies;Pearce CL;Lancet Oncol,2012